Rossari Biotech Limited (ROSSARI) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.031x

Based on the latest financial reports, Rossari Biotech Limited (ROSSARI) has a cash flow conversion efficiency ratio of 0.031x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs302.28 Million ≈ $3.27 Million USD) by net assets (Rs9.78 Billion ≈ $105.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Rossari Biotech Limited stock valuation for the company's overall valuation and market capitalisation.

Rossari Biotech Limited - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Rossari Biotech Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Rossari Biotech Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Rossari Biotech Limited ranked by their cash flow conversion efficiency. Explore Rossari Biotech Limited (ROSSARI) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
HomeStreet Inc NASDAQ:HMST	-0.024x
MEDI ASSIST HEALTHCARE SERVICES LIMITED NSE:MEDIASSIST	0.018x
Bonduelle S.C.A. PA:BON	0.324x
Ningbo GQY Video Telecom SHE:300076	-0.014x
Drugs Made In America Acquisition Corp. Ordinary Shares NASDAQ:DMAA	-0.002x
Jiangsu Jingyuan Environmental Protection Co Ltd SHG:688096	0.011x
Agora Inc NASDAQ:API	-0.004x
Pruksa Holding Public Company Limited BK:PSH	0.039x

Annual Cash Flow Conversion Efficiency for Rossari Biotech Limited (2017–2025)

The table below shows the annual cash flow conversion efficiency of Rossari Biotech Limited from 2017 to 2025. View ROSSARI live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs11.85 Billion ≈ $128.20 Million	Rs1.37 Billion ≈ $14.86 Million	0.116x	+180.84%
2024-03-31	Rs10.48 Billion ≈ $113.31 Million	Rs432.55 Million ≈ $4.68 Million	0.041x	-75.21%
2023-03-31	Rs9.15 Billion ≈ $98.97 Million	Rs1.52 Billion ≈ $16.48 Million	0.167x	+356.69%
2022-03-31	Rs8.05 Billion ≈ $87.08 Million	Rs293.58 Million ≈ $3.17 Million	0.036x	-68.80%
2021-03-31	Rs4.09 Billion ≈ $44.21 Million	Rs477.67 Million ≈ $5.17 Million	0.117x	-38.90%
2020-03-31	Rs2.87 Billion ≈ $31.00 Million	Rs548.28 Million ≈ $5.93 Million	0.191x	-66.73%
2019-03-31	Rs1.24 Billion ≈ $13.39 Million	Rs711.77 Million ≈ $7.70 Million	0.575x	+95.79%
2018-03-31	Rs870.80 Million ≈ $9.42 Million	Rs255.69 Million ≈ $2.77 Million	0.294x	+287.66%
2017-03-31	Rs619.85 Million ≈ $6.70 Million	Rs46.95 Million ≈ $507.75K	0.076x	--

About Rossari Biotech Limited

NSE:ROSSARI India Specialty Chemicals

Market Cap

$262.30 Million

Rs24.25 Billion INR

Market Cap Rank

#15551 Global

#778 in India

Share Price

Rs437.95

Change (1 day)

-0.64%

52-Week Range

Rs378.60 - Rs672.55

All Time High

Rs1568.62